Geode Capital Management, LLC Otonomy, Inc. Transaction History

Geode Capital Management, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.25 - $2.24 $241 - $2,163	966 Added 0.21%	466,500 $137,000
Q2 2022 Aug 12, 2022	BUY	$1.72 - $2.51 $10,132 - $14,786	5,891 Added 1.28%	465,534 $968,000
Q1 2022 May 13, 2022	BUY	$1.72 - $2.47 $13,658 - $19,614	7,941 Added 1.76%	459,643 $1.1 Million
Q3 2021 Nov 12, 2021	BUY	$1.22 - $2.2 $29,655 - $53,477	24,308 Added 5.69%	451,702 $867,000
Q2 2021 Aug 13, 2021	BUY	$2.06 - $2.67 $23,080 - $29,914	11,204 Added 2.69%	427,394 $953,000
Q1 2021 May 12, 2021	BUY	$2.49 - $6.23 $164,678 - $412,027	66,136 Added 18.89%	416,190 $1.06 Million
Q4 2020 Feb 12, 2021	BUY	$3.48 - $6.47 $419,545 - $780,016	120,559 Added 52.53%	350,054 $2.26 Million
Q3 2020 Nov 13, 2020	BUY	$3.16 - $4.36 $242,890 - $335,127	76,864 Added 50.36%	229,495 $929,000
Q1 2019 May 14, 2019	SELL	$1.8 - $2.97 $3,259 - $5,378	-1,811 Reduced 1.17%	152,631 $401,000
Q4 2018 Feb 13, 2019	BUY	$1.51 - $2.93 $1,783 - $3,460	1,181 Added 0.77%	154,442 $285,000
Q3 2018 Nov 13, 2018	BUY	$2.6 - $3.95 $5,792 - $8,800	2,228 Added 1.48%	153,261 $421,000
Q2 2018 Aug 14, 2018	SELL	$3.7 - $4.75 $227,191 - $291,664	-61,403 Reduced 28.9%	151,033 $581,000
Q1 2018 May 15, 2018	BUY	$4.05 - $6.1 $15,325 - $23,082	3,784 Added 1.81%	212,436 $892,000
Q4 2017 Feb 13, 2018	SELL	$2.8 - $5.55 $31,771 - $62,975	-11,347 Reduced 5.16%	208,652 $1.16 Million
Q3 2017 Nov 14, 2017	BUY	$3.2 - $20.8 $13,072 - $84,968	4,085 Added 1.89%	219,999 $714,000
Q2 2017 Aug 14, 2017	BUY	N/A	215,914	215,914 $4.07 Million

Ticker OTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,990,400
Description
Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.